Dr. Antonio Capalbo, Chief Scientific Officer at JUNO Genetics, discusses everything PGT-A: from test validation to mosaicism. He covers the importance of PGT-A, the nuances of genetics research in reproductive medicine, the impact of embryo aneuploidy on IVF outcomes, and intermediate results such as embryo mosaicism and segmental aneuploidies.
